CY1106225T1 - Διαδικασια για την παρασκευη της 2-μεθυλ πιπepαζινης - Google Patents
Διαδικασια για την παρασκευη της 2-μεθυλ πιπepαζινηςInfo
- Publication number
- CY1106225T1 CY1106225T1 CY20061101556T CY061101556T CY1106225T1 CY 1106225 T1 CY1106225 T1 CY 1106225T1 CY 20061101556 T CY20061101556 T CY 20061101556T CY 061101556 T CY061101556 T CY 061101556T CY 1106225 T1 CY1106225 T1 CY 1106225T1
- Authority
- CY
- Cyprus
- Prior art keywords
- preparation
- compound
- relates
- pipezine
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 5
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 4
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 229940076279 serotonin Drugs 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- OOZROFHKFFMSJI-OGFXRTJISA-N 2-chloro-3-[(2r)-2-methylpiperazin-1-yl]pyrazine;hydrochloride Chemical compound Cl.C[C@@H]1CNCCN1C1=NC=CN=C1Cl OOZROFHKFFMSJI-OGFXRTJISA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Pyridine Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μια διαδικασία παρασκευής ενώσεων που έχουν θεραπευτική δράση στο κεντρικό νευρικό σύστημα (ΚΝΣ). Από μια άποψη, η εφεύρεση σχετίζεται με μια διεργασία για την παρασκευή ενώσεων του γενικού τύπου (I). Επίσης η εφεύρεση σχετίζεται με την υδροχλωρική (2R)-l-(3-χλώρο-2-πυραζινύλ)-2-μεθυλπιπεραζίνη, και μια διεργασία για την παρασκευή της ίδιας. Ένας άλλος σκοπός της εφεύρεσης είναι μια ένωση του τύπου (I). Ένας άλλος σκοπός της παρούσας εφεύρεσης είναι μια μέθοδος για την θεραπεία ή την προφύλαξη διαταραχών που σχετίζονται με την σεροτονίνη. Η μέθοδος περιλαμβάνει την χορήγηση μιας δραστικής ποσότητας της ένωσης σε έναν οργανισμό που την έχει ανάγκη καθώς επίσης και την χρήση της εν λόγω ένωσης στην παρασκευή ενός φαρμάκου για την θεραπεία μιας διαταραχής που σχετίζεται με την σεροτονίνη.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201881A SE0201881D0 (sv) | 2002-06-19 | 2002-06-19 | Novel compounds, their use, and preparation |
| US39065602P | 2002-06-21 | 2002-06-21 | |
| SE0202041A SE0202041D0 (sv) | 2002-06-28 | 2002-06-28 | Novel process |
| US40611902P | 2002-08-26 | 2002-08-26 | |
| SE0202516A SE0202516D0 (sv) | 2002-08-26 | 2002-08-26 | Novel compounds, their use, and preparation |
| US41670102P | 2002-10-07 | 2002-10-07 | |
| PCT/SE2003/001043 WO2004000829A1 (en) | 2002-06-19 | 2003-06-18 | Novel process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106225T1 true CY1106225T1 (el) | 2011-06-08 |
Family
ID=30004077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061101556T CY1106225T1 (el) | 2002-06-19 | 2006-10-30 | Διαδικασια για την παρασκευη της 2-μεθυλ πιπepαζινης |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP1529043B1 (el) |
| JP (4) | JP4592417B2 (el) |
| CN (1) | CN100334082C (el) |
| AT (2) | ATE334980T1 (el) |
| AU (1) | AU2003237746B8 (el) |
| CA (1) | CA2485532C (el) |
| CY (1) | CY1106225T1 (el) |
| DE (2) | DE60307286T2 (el) |
| DK (2) | DK1529043T3 (el) |
| ES (2) | ES2307102T3 (el) |
| HK (1) | HK1080079B (el) |
| NO (1) | NO20050279D0 (el) |
| NZ (1) | NZ536663A (el) |
| PT (2) | PT1529043E (el) |
| SI (2) | SI1645558T1 (el) |
| WO (1) | WO2004000829A1 (el) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8685924B2 (en) | 2004-08-25 | 2014-04-01 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| EP2742936A1 (en) | 2006-05-16 | 2014-06-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
| WO2009051119A1 (ja) | 2007-10-16 | 2009-04-23 | Daiichi Sankyo Company, Limited | ピリミジルインドリン化合物 |
| US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
| US8318722B2 (en) | 2009-06-15 | 2012-11-27 | Takeda Pharmaceutical Company Limited | Pyrazinooxazepine derivatives |
| US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
| GB201304811D0 (en) * | 2013-03-15 | 2013-05-01 | Proximagen Ltd | Novel treatment for hypertension |
| EP3733204A4 (en) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06306075A (ja) * | 1993-04-23 | 1994-11-01 | Sanwa Kagaku Kenkyusho Co Ltd | エトキシベンズアミド誘導体 |
| MXPA01011905A (es) * | 1999-05-21 | 2004-03-19 | Biovitrum Ab | Compuestos novedosos, su uso y preparacion. |
| AR032318A1 (es) * | 2000-04-13 | 2003-11-05 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa |
| CN1227237C (zh) * | 2000-11-20 | 2005-11-16 | 比奥维特罗姆股份公司 | 作为五羟色胺5－ht2受体拮抗剂的哌嗪基吡嗪化合物 |
-
2003
- 2003-06-18 JP JP2004530934A patent/JP4592417B2/ja not_active Expired - Fee Related
- 2003-06-18 NZ NZ536663A patent/NZ536663A/en not_active IP Right Cessation
- 2003-06-18 DK DK03736405T patent/DK1529043T3/da active
- 2003-06-18 ES ES05023471T patent/ES2307102T3/es not_active Expired - Lifetime
- 2003-06-18 DE DE60307286T patent/DE60307286T2/de not_active Expired - Lifetime
- 2003-06-18 AT AT03736405T patent/ATE334980T1/de active
- 2003-06-18 SI SI200331283T patent/SI1645558T1/sl unknown
- 2003-06-18 EP EP03736405A patent/EP1529043B1/en not_active Expired - Lifetime
- 2003-06-18 WO PCT/SE2003/001043 patent/WO2004000829A1/en active IP Right Grant
- 2003-06-18 DK DK05023471T patent/DK1645558T3/da active
- 2003-06-18 AU AU2003237746A patent/AU2003237746B8/en not_active Ceased
- 2003-06-18 EP EP05023471A patent/EP1645558B1/en not_active Expired - Lifetime
- 2003-06-18 SI SI200330493T patent/SI1529043T1/sl unknown
- 2003-06-18 AT AT05023471T patent/ATE398119T1/de active
- 2003-06-18 ES ES03736405T patent/ES2270051T3/es not_active Expired - Lifetime
- 2003-06-18 DE DE60321606T patent/DE60321606D1/de not_active Expired - Lifetime
- 2003-06-18 PT PT03736405T patent/PT1529043E/pt unknown
- 2003-06-18 CA CA2485532A patent/CA2485532C/en not_active Expired - Fee Related
- 2003-06-18 CN CNB038141612A patent/CN100334082C/zh not_active Expired - Fee Related
- 2003-06-18 PT PT05023471T patent/PT1645558E/pt unknown
-
2005
- 2005-01-18 NO NO20050279A patent/NO20050279D0/no not_active Application Discontinuation
-
2006
- 2006-01-04 HK HK06100135.0A patent/HK1080079B/zh not_active IP Right Cessation
- 2006-10-30 CY CY20061101556T patent/CY1106225T1/el unknown
-
2010
- 2010-01-07 JP JP2010002229A patent/JP5378241B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-04 JP JP2013019444A patent/JP2013116906A/ja active Pending
- 2013-07-08 JP JP2013142942A patent/JP2013227336A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106225T1 (el) | Διαδικασια για την παρασκευη της 2-μεθυλ πιπepαζινης | |
| CY1121330T1 (el) | Συνθεσεις που περιλαμβανουν αζελαστινη και μεθοδοι χρησης αυτων | |
| CY1105053T1 (el) | Υποκατεστημενες ομοιαζουσες με ινδολιζινη ενωσεις και μεθοδοι χρησης | |
| CY1124763T1 (el) | Μεθοδος για την θεραπευτικη αντιμετωπιση της πρωτοπαθους αϋπνιας | |
| BR0311494A (pt) | Novos indóis substituìdos | |
| CY1106645T1 (el) | Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος | |
| EA200601269A1 (ru) | Лекарственное средство, содержащее производные фенилпиперазина | |
| EA200500018A1 (ru) | Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения | |
| CY1106697T1 (el) | Ν-υποκατεστημενες υδρομορφονες και η χρηση αυτων | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| ECSP055719A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos | |
| BR0207526A (pt) | Composto, composição farmacêutica, e, métodos para o tratamento da dor, da enxaqueca, depressão, ansiedade, esquizofrenia, doença de parkinson ou derrame cerebral | |
| CY1112689T1 (el) | Συνθεση για τη βελτιωση της γνωσης και της μνημης | |
| EA200200716A1 (ru) | Арилконденсированные азаполициклические соединения | |
| ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
| DE60315492D1 (de) | Medizinisch verwendbare arylethanolamin verbindungen | |
| ATE316076T1 (de) | Benzimidazol-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| CY1110977T1 (el) | Υποκατεστημενα παραγωγα ινδολης για φαρμακευτικη συνθεση για θεραπεια ασθενειων του αναπνευστικου | |
| CY1109355T1 (el) | Πυριμιδινες υποκατεστημενες με αρυλιο και η χρηση αυτων | |
| BR0212613A (pt) | Compostos de indazol substituìdos para o tratamento de inflamação | |
| CY1112349T1 (el) | Αντισπασμωδικα αμινοξεα για τη θεραπευτικη αγωγη ψυχαναγκαστικης-καταναγκαστικης νευρωσης | |
| ATE358668T1 (de) | Drogen zur behandlung maligner tumoren | |
| CY1114400T1 (el) | Θεραπευτικες εφαρμογες των παραγωγων κιναζολινεδιονης | |
| BR0312722A (pt) | Derivados de pirazol heterobicìclico como inibidores de qinase | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes |